nodes	percent_of_prediction	percent_of_DWPC	metapath
Felbamate—CYP2E1—Fingolimod—multiple sclerosis	0.186	0.299	CbGbCtD
Felbamate—CYP2E1—Mitoxantrone—multiple sclerosis	0.0876	0.141	CbGbCtD
Felbamate—CYP3A4—Fingolimod—multiple sclerosis	0.0565	0.0906	CbGbCtD
Felbamate—CYP2C19—Prednisone—multiple sclerosis	0.0456	0.0732	CbGbCtD
Felbamate—CYP2E1—Dexamethasone—multiple sclerosis	0.0454	0.0729	CbGbCtD
Felbamate—CYP3A4—Methylprednisolone—multiple sclerosis	0.0364	0.0584	CbGbCtD
Felbamate—CYP2C19—Dexamethasone—multiple sclerosis	0.0285	0.0457	CbGbCtD
Felbamate—CYP3A4—Triamcinolone—multiple sclerosis	0.0276	0.0442	CbGbCtD
Felbamate—CYP3A4—Mitoxantrone—multiple sclerosis	0.0265	0.0426	CbGbCtD
Felbamate—CYP3A4—Betamethasone—multiple sclerosis	0.0237	0.038	CbGbCtD
Felbamate—CYP3A4—Prednisolone—multiple sclerosis	0.0233	0.0375	CbGbCtD
Felbamate—CYP3A4—Prednisone—multiple sclerosis	0.022	0.0354	CbGbCtD
Felbamate—CYP3A4—Dexamethasone—multiple sclerosis	0.0138	0.0221	CbGbCtD
Felbamate—GRIN2B—nerve—multiple sclerosis	0.0109	0.157	CbGeAlD
Felbamate—GRIN2A—nerve—multiple sclerosis	0.0095	0.137	CbGeAlD
Felbamate—GRIN2B—brainstem—multiple sclerosis	0.00467	0.0673	CbGeAlD
Felbamate—GRIN2A—brainstem—multiple sclerosis	0.00408	0.0589	CbGeAlD
Felbamate—GRIN2B—spinal cord—multiple sclerosis	0.0029	0.0419	CbGeAlD
Felbamate—GRIN2A—medulla oblongata—multiple sclerosis	0.00284	0.041	CbGeAlD
Felbamate—GRIN3A—nervous system—multiple sclerosis	0.0027	0.039	CbGeAlD
Felbamate—GRIN3A—central nervous system—multiple sclerosis	0.0026	0.0376	CbGeAlD
Felbamate—GRIN2A—midbrain—multiple sclerosis	0.0026	0.0375	CbGeAlD
Felbamate—GRIN2A—spinal cord—multiple sclerosis	0.00254	0.0366	CbGeAlD
Felbamate—GRIN2B—nervous system—multiple sclerosis	0.00245	0.0353	CbGeAlD
Felbamate—GRIN2B—central nervous system—multiple sclerosis	0.00235	0.034	CbGeAlD
Felbamate—GRIN2B—cerebellum—multiple sclerosis	0.0023	0.0332	CbGeAlD
Felbamate—GRIN2A—nervous system—multiple sclerosis	0.00214	0.0308	CbGeAlD
Felbamate—GRIN3A—brain—multiple sclerosis	0.00207	0.0298	CbGeAlD
Felbamate—GRIN2A—central nervous system—multiple sclerosis	0.00206	0.0297	CbGeAlD
Felbamate—GRIN2A—cerebellum—multiple sclerosis	0.00201	0.029	CbGeAlD
Felbamate—GRIN2B—brain—multiple sclerosis	0.00187	0.027	CbGeAlD
Felbamate—GRIN2A—brain—multiple sclerosis	0.00163	0.0236	CbGeAlD
Felbamate—CYP2E1—medulla oblongata—multiple sclerosis	0.000876	0.0126	CbGeAlD
Felbamate—CYP2E1—spinal cord—multiple sclerosis	0.000781	0.0113	CbGeAlD
Felbamate—CYP2E1—nervous system—multiple sclerosis	0.000658	0.00949	CbGeAlD
Felbamate—CYP2E1—central nervous system—multiple sclerosis	0.000633	0.00914	CbGeAlD
Felbamate—CYP2E1—cerebellum—multiple sclerosis	0.000619	0.00893	CbGeAlD
Felbamate—CYP3A4—nervous system—multiple sclerosis	0.000529	0.00764	CbGeAlD
Felbamate—CYP3A4—central nervous system—multiple sclerosis	0.00051	0.00735	CbGeAlD
Felbamate—CYP2E1—brain—multiple sclerosis	0.000503	0.00726	CbGeAlD
Felbamate—Upper respiratory tract infection—Methotrexate—multiple sclerosis	0.000209	0.000689	CcSEcCtD
Felbamate—Cough—Triamcinolone—multiple sclerosis	0.000207	0.000683	CcSEcCtD
Felbamate—Tachycardia—Prednisolone—multiple sclerosis	0.000205	0.000677	CcSEcCtD
Felbamate—Photosensitivity reaction—Methotrexate—multiple sclerosis	0.000205	0.000677	CcSEcCtD
Felbamate—Hypertension—Triamcinolone—multiple sclerosis	0.000205	0.000675	CcSEcCtD
Felbamate—Hypertension—Methylprednisolone—multiple sclerosis	0.000204	0.000674	CcSEcCtD
Felbamate—Urticaria—Mitoxantrone—multiple sclerosis	0.000204	0.000672	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisolone—multiple sclerosis	0.000203	0.000671	CcSEcCtD
Felbamate—Body temperature increased—Mitoxantrone—multiple sclerosis	0.000203	0.000669	CcSEcCtD
Felbamate—Abdominal pain—Mitoxantrone—multiple sclerosis	0.000203	0.000669	CcSEcCtD
Felbamate—Myalgia—Triamcinolone—multiple sclerosis	0.000202	0.000666	CcSEcCtD
Felbamate—Vomiting—Azathioprine—multiple sclerosis	0.000202	0.000665	CcSEcCtD
Felbamate—Pneumonia—Methotrexate—multiple sclerosis	0.000202	0.000665	CcSEcCtD
Felbamate—Myalgia—Methylprednisolone—multiple sclerosis	0.000201	0.000664	CcSEcCtD
Felbamate—Arthralgia—Methylprednisolone—multiple sclerosis	0.000201	0.000664	CcSEcCtD
Felbamate—Anxiety—Methylprednisolone—multiple sclerosis	0.000201	0.000662	CcSEcCtD
Felbamate—Rash—Azathioprine—multiple sclerosis	0.0002	0.00066	CcSEcCtD
Felbamate—Dermatitis—Azathioprine—multiple sclerosis	0.0002	0.000659	CcSEcCtD
Felbamate—Depression—Methotrexate—multiple sclerosis	0.0002	0.000659	CcSEcCtD
Felbamate—Flushing—Prednisone—multiple sclerosis	0.0002	0.000659	CcSEcCtD
Felbamate—Ill-defined disorder—Dexamethasone—multiple sclerosis	0.0002	0.000658	CcSEcCtD
Felbamate—Ill-defined disorder—Betamethasone—multiple sclerosis	0.0002	0.000658	CcSEcCtD
Felbamate—Discomfort—Triamcinolone—multiple sclerosis	0.000199	0.000658	CcSEcCtD
Felbamate—Discomfort—Methylprednisolone—multiple sclerosis	0.000199	0.000656	CcSEcCtD
Felbamate—Headache—Azathioprine—multiple sclerosis	0.000199	0.000656	CcSEcCtD
Felbamate—Stevens-Johnson syndrome—Methotrexate—multiple sclerosis	0.000199	0.000655	CcSEcCtD
Felbamate—Dry mouth—Triamcinolone—multiple sclerosis	0.000197	0.000651	CcSEcCtD
Felbamate—Conjunctivitis—Methotrexate—multiple sclerosis	0.000195	0.000642	CcSEcCtD
Felbamate—Confusional state—Methylprednisolone—multiple sclerosis	0.000195	0.000642	CcSEcCtD
Felbamate—Malaise—Dexamethasone—multiple sclerosis	0.000194	0.00064	CcSEcCtD
Felbamate—Malaise—Betamethasone—multiple sclerosis	0.000194	0.00064	CcSEcCtD
Felbamate—Anaphylactic shock—Triamcinolone—multiple sclerosis	0.000194	0.000638	CcSEcCtD
Felbamate—Oedema—Triamcinolone—multiple sclerosis	0.000194	0.000638	CcSEcCtD
Felbamate—Anaphylactic shock—Methylprednisolone—multiple sclerosis	0.000193	0.000637	CcSEcCtD
Felbamate—Infection—Triamcinolone—multiple sclerosis	0.000192	0.000634	CcSEcCtD
Felbamate—Sweating—Methotrexate—multiple sclerosis	0.000192	0.000634	CcSEcCtD
Felbamate—Infection—Methylprednisolone—multiple sclerosis	0.000192	0.000633	CcSEcCtD
Felbamate—Haematuria—Methotrexate—multiple sclerosis	0.000191	0.00063	CcSEcCtD
Felbamate—Insomnia—Prednisolone—multiple sclerosis	0.00019	0.000628	CcSEcCtD
Felbamate—Alopecia—Prednisone—multiple sclerosis	0.00019	0.000627	CcSEcCtD
Felbamate—Epistaxis—Methotrexate—multiple sclerosis	0.000189	0.000623	CcSEcCtD
Felbamate—Paraesthesia—Prednisolone—multiple sclerosis	0.000189	0.000623	CcSEcCtD
Felbamate—Tachycardia—Triamcinolone—multiple sclerosis	0.000189	0.000623	CcSEcCtD
Felbamate—Nausea—Azathioprine—multiple sclerosis	0.000189	0.000622	CcSEcCtD
Felbamate—Tachycardia—Methylprednisolone—multiple sclerosis	0.000188	0.000622	CcSEcCtD
Felbamate—Hyperhidrosis—Triamcinolone—multiple sclerosis	0.000187	0.000617	CcSEcCtD
Felbamate—Agranulocytosis—Methotrexate—multiple sclerosis	0.000187	0.000617	CcSEcCtD
Felbamate—Hyperhidrosis—Methylprednisolone—multiple sclerosis	0.000187	0.000616	CcSEcCtD
Felbamate—Hypertension—Betamethasone—multiple sclerosis	0.000186	0.000613	CcSEcCtD
Felbamate—Hypertension—Dexamethasone—multiple sclerosis	0.000186	0.000613	CcSEcCtD
Felbamate—Asthenia—Mitoxantrone—multiple sclerosis	0.000184	0.000607	CcSEcCtD
Felbamate—Myalgia—Dexamethasone—multiple sclerosis	0.000183	0.000604	CcSEcCtD
Felbamate—Myalgia—Betamethasone—multiple sclerosis	0.000183	0.000604	CcSEcCtD
Felbamate—Anxiety—Betamethasone—multiple sclerosis	0.000183	0.000602	CcSEcCtD
Felbamate—Anxiety—Dexamethasone—multiple sclerosis	0.000183	0.000602	CcSEcCtD
Felbamate—Discomfort—Betamethasone—multiple sclerosis	0.000181	0.000597	CcSEcCtD
Felbamate—Discomfort—Dexamethasone—multiple sclerosis	0.000181	0.000597	CcSEcCtD
Felbamate—Haemoglobin—Methotrexate—multiple sclerosis	0.000181	0.000596	CcSEcCtD
Felbamate—Hypotension—Methylprednisolone—multiple sclerosis	0.00018	0.000595	CcSEcCtD
Felbamate—Pain—Prednisolone—multiple sclerosis	0.00018	0.000594	CcSEcCtD
Felbamate—Haemorrhage—Methotrexate—multiple sclerosis	0.00018	0.000593	CcSEcCtD
Felbamate—Hepatitis—Methotrexate—multiple sclerosis	0.00018	0.000593	CcSEcCtD
Felbamate—Pharyngitis—Methotrexate—multiple sclerosis	0.000179	0.000589	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Triamcinolone—multiple sclerosis	0.000176	0.000582	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methylprednisolone—multiple sclerosis	0.000176	0.00058	CcSEcCtD
Felbamate—Anaphylactic shock—Dexamethasone—multiple sclerosis	0.000176	0.000579	CcSEcCtD
Felbamate—Oedema—Betamethasone—multiple sclerosis	0.000176	0.000579	CcSEcCtD
Felbamate—Anaphylactic shock—Betamethasone—multiple sclerosis	0.000176	0.000579	CcSEcCtD
Felbamate—Oedema—Dexamethasone—multiple sclerosis	0.000176	0.000579	CcSEcCtD
Felbamate—Diarrhoea—Mitoxantrone—multiple sclerosis	0.000176	0.000579	CcSEcCtD
Felbamate—Insomnia—Triamcinolone—multiple sclerosis	0.000175	0.000577	CcSEcCtD
Felbamate—Insomnia—Methylprednisolone—multiple sclerosis	0.000175	0.000576	CcSEcCtD
Felbamate—Infection—Betamethasone—multiple sclerosis	0.000174	0.000575	CcSEcCtD
Felbamate—Infection—Dexamethasone—multiple sclerosis	0.000174	0.000575	CcSEcCtD
Felbamate—Ill-defined disorder—Prednisone—multiple sclerosis	0.000174	0.000573	CcSEcCtD
Felbamate—Paraesthesia—Triamcinolone—multiple sclerosis	0.000174	0.000573	CcSEcCtD
Felbamate—Feeling abnormal—Prednisolone—multiple sclerosis	0.000173	0.000572	CcSEcCtD
Felbamate—Paraesthesia—Methylprednisolone—multiple sclerosis	0.000173	0.000572	CcSEcCtD
Felbamate—Visual impairment—Methotrexate—multiple sclerosis	0.000173	0.000572	CcSEcCtD
Felbamate—Anaemia—Prednisone—multiple sclerosis	0.000173	0.000571	CcSEcCtD
Felbamate—Dyspnoea—Triamcinolone—multiple sclerosis	0.000173	0.000569	CcSEcCtD
Felbamate—Agitation—Prednisone—multiple sclerosis	0.000172	0.000568	CcSEcCtD
Felbamate—Thrombocytopenia—Dexamethasone—multiple sclerosis	0.000172	0.000567	CcSEcCtD
Felbamate—Thrombocytopenia—Betamethasone—multiple sclerosis	0.000172	0.000567	CcSEcCtD
Felbamate—Tachycardia—Dexamethasone—multiple sclerosis	0.000171	0.000565	CcSEcCtD
Felbamate—Tachycardia—Betamethasone—multiple sclerosis	0.000171	0.000565	CcSEcCtD
Felbamate—Dyspepsia—Triamcinolone—multiple sclerosis	0.00017	0.000562	CcSEcCtD
Felbamate—Erythema multiforme—Methotrexate—multiple sclerosis	0.00017	0.000561	CcSEcCtD
Felbamate—Dyspepsia—Methylprednisolone—multiple sclerosis	0.00017	0.000561	CcSEcCtD
Felbamate—Hyperhidrosis—Betamethasone—multiple sclerosis	0.00017	0.00056	CcSEcCtD
Felbamate—Hyperhidrosis—Dexamethasone—multiple sclerosis	0.00017	0.00056	CcSEcCtD
Felbamate—Malaise—Prednisone—multiple sclerosis	0.000169	0.000557	CcSEcCtD
Felbamate—Anorexia—Betamethasone—multiple sclerosis	0.000167	0.000552	CcSEcCtD
Felbamate—Anorexia—Dexamethasone—multiple sclerosis	0.000167	0.000552	CcSEcCtD
Felbamate—Urticaria—Prednisolone—multiple sclerosis	0.000167	0.000551	CcSEcCtD
Felbamate—Fatigue—Triamcinolone—multiple sclerosis	0.000167	0.00055	CcSEcCtD
Felbamate—Fatigue—Methylprednisolone—multiple sclerosis	0.000167	0.000549	CcSEcCtD
Felbamate—Pain—Triamcinolone—multiple sclerosis	0.000166	0.000546	CcSEcCtD
Felbamate—Hypotension—Betamethasone—multiple sclerosis	0.000164	0.000541	CcSEcCtD
Felbamate—Hypotension—Dexamethasone—multiple sclerosis	0.000164	0.000541	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—KCNA3—multiple sclerosis	0.000164	0.0385	CbGpPWpGaD
Felbamate—Vomiting—Mitoxantrone—multiple sclerosis	0.000163	0.000538	CcSEcCtD
Felbamate—Hypertension—Prednisone—multiple sclerosis	0.000162	0.000534	CcSEcCtD
Felbamate—Rash—Mitoxantrone—multiple sclerosis	0.000162	0.000533	CcSEcCtD
Felbamate—Dermatitis—Mitoxantrone—multiple sclerosis	0.000162	0.000533	CcSEcCtD
Felbamate—Chills—Methotrexate—multiple sclerosis	0.000161	0.000532	CcSEcCtD
Felbamate—Headache—Mitoxantrone—multiple sclerosis	0.000161	0.00053	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Dexamethasone—multiple sclerosis	0.00016	0.000528	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Betamethasone—multiple sclerosis	0.00016	0.000528	CcSEcCtD
Felbamate—Myalgia—Prednisone—multiple sclerosis	0.00016	0.000526	CcSEcCtD
Felbamate—Arthralgia—Prednisone—multiple sclerosis	0.00016	0.000526	CcSEcCtD
Felbamate—Feeling abnormal—Triamcinolone—multiple sclerosis	0.000159	0.000526	CcSEcCtD
Felbamate—Feeling abnormal—Methylprednisolone—multiple sclerosis	0.000159	0.000525	CcSEcCtD
Felbamate—Anxiety—Prednisone—multiple sclerosis	0.000159	0.000524	CcSEcCtD
Felbamate—Alopecia—Methotrexate—multiple sclerosis	0.000159	0.000524	CcSEcCtD
Felbamate—Insomnia—Dexamethasone—multiple sclerosis	0.000159	0.000524	CcSEcCtD
Felbamate—Insomnia—Betamethasone—multiple sclerosis	0.000159	0.000524	CcSEcCtD
Felbamate—Gastrointestinal pain—Methylprednisolone—multiple sclerosis	0.000158	0.000521	CcSEcCtD
Felbamate—Paraesthesia—Dexamethasone—multiple sclerosis	0.000158	0.00052	CcSEcCtD
Felbamate—Paraesthesia—Betamethasone—multiple sclerosis	0.000158	0.00052	CcSEcCtD
Felbamate—Discomfort—Prednisone—multiple sclerosis	0.000158	0.00052	CcSEcCtD
Felbamate—Dyspepsia—Dexamethasone—multiple sclerosis	0.000155	0.00051	CcSEcCtD
Felbamate—Dyspepsia—Betamethasone—multiple sclerosis	0.000155	0.00051	CcSEcCtD
Felbamate—Urticaria—Triamcinolone—multiple sclerosis	0.000154	0.000507	CcSEcCtD
Felbamate—Urticaria—Methylprednisolone—multiple sclerosis	0.000153	0.000506	CcSEcCtD
Felbamate—Dysgeusia—Methotrexate—multiple sclerosis	0.000153	0.000506	CcSEcCtD
Felbamate—Body temperature increased—Triamcinolone—multiple sclerosis	0.000153	0.000505	CcSEcCtD
Felbamate—Anaphylactic shock—Prednisone—multiple sclerosis	0.000153	0.000504	CcSEcCtD
Felbamate—Oedema—Prednisone—multiple sclerosis	0.000153	0.000504	CcSEcCtD
Felbamate—Abdominal pain—Methylprednisolone—multiple sclerosis	0.000153	0.000503	CcSEcCtD
Felbamate—Decreased appetite—Dexamethasone—multiple sclerosis	0.000153	0.000503	CcSEcCtD
Felbamate—Decreased appetite—Betamethasone—multiple sclerosis	0.000153	0.000503	CcSEcCtD
Felbamate—Nausea—Mitoxantrone—multiple sclerosis	0.000152	0.000503	CcSEcCtD
Felbamate—Infection—Prednisone—multiple sclerosis	0.000152	0.000501	CcSEcCtD
Felbamate—Fatigue—Betamethasone—multiple sclerosis	0.000151	0.000499	CcSEcCtD
Felbamate—Fatigue—Dexamethasone—multiple sclerosis	0.000151	0.000499	CcSEcCtD
Felbamate—Pain—Dexamethasone—multiple sclerosis	0.00015	0.000495	CcSEcCtD
Felbamate—Pain—Betamethasone—multiple sclerosis	0.00015	0.000495	CcSEcCtD
Felbamate—Tachycardia—Prednisone—multiple sclerosis	0.000149	0.000492	CcSEcCtD
Felbamate—Hyperhidrosis—Prednisone—multiple sclerosis	0.000148	0.000488	CcSEcCtD
Felbamate—Anorexia—Prednisone—multiple sclerosis	0.000146	0.000481	CcSEcCtD
Felbamate—Ill-defined disorder—Methotrexate—multiple sclerosis	0.000145	0.000479	CcSEcCtD
Felbamate—Anaemia—Methotrexate—multiple sclerosis	0.000145	0.000477	CcSEcCtD
Felbamate—Feeling abnormal—Betamethasone—multiple sclerosis	0.000145	0.000477	CcSEcCtD
Felbamate—Feeling abnormal—Dexamethasone—multiple sclerosis	0.000145	0.000477	CcSEcCtD
Felbamate—Gastrointestinal pain—Dexamethasone—multiple sclerosis	0.000144	0.000474	CcSEcCtD
Felbamate—Gastrointestinal pain—Betamethasone—multiple sclerosis	0.000144	0.000474	CcSEcCtD
Felbamate—Malaise—Methotrexate—multiple sclerosis	0.000141	0.000466	CcSEcCtD
Felbamate—Leukopenia—Methotrexate—multiple sclerosis	0.00014	0.000462	CcSEcCtD
Felbamate—Urticaria—Dexamethasone—multiple sclerosis	0.00014	0.00046	CcSEcCtD
Felbamate—Urticaria—Betamethasone—multiple sclerosis	0.00014	0.00046	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Prednisone—multiple sclerosis	0.000139	0.00046	CcSEcCtD
Felbamate—Dizziness—Prednisolone—multiple sclerosis	0.000139	0.000459	CcSEcCtD
Felbamate—Asthenia—Triamcinolone—multiple sclerosis	0.000139	0.000458	CcSEcCtD
Felbamate—Abdominal pain—Dexamethasone—multiple sclerosis	0.000139	0.000458	CcSEcCtD
Felbamate—Abdominal pain—Betamethasone—multiple sclerosis	0.000139	0.000458	CcSEcCtD
Felbamate—Body temperature increased—Dexamethasone—multiple sclerosis	0.000139	0.000458	CcSEcCtD
Felbamate—Body temperature increased—Betamethasone—multiple sclerosis	0.000139	0.000458	CcSEcCtD
Felbamate—Asthenia—Methylprednisolone—multiple sclerosis	0.000139	0.000457	CcSEcCtD
Felbamate—Insomnia—Prednisone—multiple sclerosis	0.000138	0.000456	CcSEcCtD
Felbamate—Paraesthesia—Prednisone—multiple sclerosis	0.000137	0.000453	CcSEcCtD
Felbamate—Pruritus—Triamcinolone—multiple sclerosis	0.000137	0.000452	CcSEcCtD
Felbamate—Cough—Methotrexate—multiple sclerosis	0.000137	0.000451	CcSEcCtD
Felbamate—Pruritus—Methylprednisolone—multiple sclerosis	0.000137	0.000451	CcSEcCtD
Felbamate—Dyspepsia—Prednisone—multiple sclerosis	0.000135	0.000444	CcSEcCtD
Felbamate—Myalgia—Methotrexate—multiple sclerosis	0.000133	0.00044	CcSEcCtD
Felbamate—Chest pain—Methotrexate—multiple sclerosis	0.000133	0.00044	CcSEcCtD
Felbamate—Arthralgia—Methotrexate—multiple sclerosis	0.000133	0.00044	CcSEcCtD
Felbamate—Decreased appetite—Prednisone—multiple sclerosis	0.000133	0.000438	CcSEcCtD
Felbamate—Rash—Prednisolone—multiple sclerosis	0.000133	0.000438	CcSEcCtD
Felbamate—Dermatitis—Prednisolone—multiple sclerosis	0.000133	0.000437	CcSEcCtD
Felbamate—Diarrhoea—Methylprednisolone—multiple sclerosis	0.000132	0.000436	CcSEcCtD
Felbamate—Fatigue—Prednisone—multiple sclerosis	0.000132	0.000435	CcSEcCtD
Felbamate—Headache—Prednisolone—multiple sclerosis	0.000132	0.000435	CcSEcCtD
Felbamate—Discomfort—Methotrexate—multiple sclerosis	0.000132	0.000434	CcSEcCtD
Felbamate—Constipation—Prednisone—multiple sclerosis	0.000131	0.000431	CcSEcCtD
Felbamate—GRIN2B—BDNF signaling pathway—LINGO1—multiple sclerosis	0.000131	0.0308	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	0.000129	0.0305	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	0.000129	0.0305	CbGpPWpGaD
Felbamate—Confusional state—Methotrexate—multiple sclerosis	0.000129	0.000425	CcSEcCtD
Felbamate—Dizziness—Triamcinolone—multiple sclerosis	0.000128	0.000422	CcSEcCtD
Felbamate—Anaphylactic shock—Methotrexate—multiple sclerosis	0.000128	0.000422	CcSEcCtD
Felbamate—Dizziness—Methylprednisolone—multiple sclerosis	0.000128	0.000421	CcSEcCtD
Felbamate—Infection—Methotrexate—multiple sclerosis	0.000127	0.000419	CcSEcCtD
Felbamate—Feeling abnormal—Prednisone—multiple sclerosis	0.000126	0.000416	CcSEcCtD
Felbamate—Asthenia—Dexamethasone—multiple sclerosis	0.000126	0.000416	CcSEcCtD
Felbamate—Asthenia—Betamethasone—multiple sclerosis	0.000126	0.000416	CcSEcCtD
Felbamate—Thrombocytopenia—Methotrexate—multiple sclerosis	0.000125	0.000413	CcSEcCtD
Felbamate—Gastrointestinal pain—Prednisone—multiple sclerosis	0.000125	0.000412	CcSEcCtD
Felbamate—Nausea—Prednisolone—multiple sclerosis	0.000125	0.000412	CcSEcCtD
Felbamate—Pruritus—Betamethasone—multiple sclerosis	0.000124	0.00041	CcSEcCtD
Felbamate—Pruritus—Dexamethasone—multiple sclerosis	0.000124	0.00041	CcSEcCtD
Felbamate—Hyperhidrosis—Methotrexate—multiple sclerosis	0.000124	0.000408	CcSEcCtD
Felbamate—Vomiting—Triamcinolone—multiple sclerosis	0.000123	0.000406	CcSEcCtD
Felbamate—Vomiting—Methylprednisolone—multiple sclerosis	0.000123	0.000405	CcSEcCtD
Felbamate—Rash—Triamcinolone—multiple sclerosis	0.000122	0.000402	CcSEcCtD
Felbamate—Dermatitis—Triamcinolone—multiple sclerosis	0.000122	0.000402	CcSEcCtD
Felbamate—Anorexia—Methotrexate—multiple sclerosis	0.000122	0.000402	CcSEcCtD
Felbamate—Rash—Methylprednisolone—multiple sclerosis	0.000122	0.000402	CcSEcCtD
Felbamate—Dermatitis—Methylprednisolone—multiple sclerosis	0.000122	0.000401	CcSEcCtD
Felbamate—Urticaria—Prednisone—multiple sclerosis	0.000122	0.000401	CcSEcCtD
Felbamate—Headache—Triamcinolone—multiple sclerosis	0.000121	0.0004	CcSEcCtD
Felbamate—Headache—Methylprednisolone—multiple sclerosis	0.000121	0.000399	CcSEcCtD
Felbamate—Abdominal pain—Prednisone—multiple sclerosis	0.000121	0.000399	CcSEcCtD
Felbamate—Body temperature increased—Prednisone—multiple sclerosis	0.000121	0.000399	CcSEcCtD
Felbamate—Diarrhoea—Dexamethasone—multiple sclerosis	0.00012	0.000396	CcSEcCtD
Felbamate—Diarrhoea—Betamethasone—multiple sclerosis	0.00012	0.000396	CcSEcCtD
Felbamate—Hypotension—Methotrexate—multiple sclerosis	0.000119	0.000394	CcSEcCtD
Felbamate—Musculoskeletal discomfort—Methotrexate—multiple sclerosis	0.000116	0.000384	CcSEcCtD
Felbamate—Dizziness—Dexamethasone—multiple sclerosis	0.000116	0.000383	CcSEcCtD
Felbamate—Dizziness—Betamethasone—multiple sclerosis	0.000116	0.000383	CcSEcCtD
Felbamate—Insomnia—Methotrexate—multiple sclerosis	0.000116	0.000381	CcSEcCtD
Felbamate—Nausea—Triamcinolone—multiple sclerosis	0.000115	0.000379	CcSEcCtD
Felbamate—Paraesthesia—Methotrexate—multiple sclerosis	0.000115	0.000379	CcSEcCtD
Felbamate—Nausea—Methylprednisolone—multiple sclerosis	0.000115	0.000378	CcSEcCtD
Felbamate—Dyspnoea—Methotrexate—multiple sclerosis	0.000114	0.000376	CcSEcCtD
Felbamate—Somnolence—Methotrexate—multiple sclerosis	0.000114	0.000375	CcSEcCtD
Felbamate—GRIN2A—Neuronal System—KCNA3—multiple sclerosis	0.000113	0.0267	CbGpPWpGaD
Felbamate—Dyspepsia—Methotrexate—multiple sclerosis	0.000113	0.000371	CcSEcCtD
Felbamate—Vomiting—Dexamethasone—multiple sclerosis	0.000112	0.000368	CcSEcCtD
Felbamate—Vomiting—Betamethasone—multiple sclerosis	0.000112	0.000368	CcSEcCtD
Felbamate—Decreased appetite—Methotrexate—multiple sclerosis	0.000111	0.000366	CcSEcCtD
Felbamate—Rash—Dexamethasone—multiple sclerosis	0.000111	0.000365	CcSEcCtD
Felbamate—Rash—Betamethasone—multiple sclerosis	0.000111	0.000365	CcSEcCtD
Felbamate—Dermatitis—Dexamethasone—multiple sclerosis	0.000111	0.000365	CcSEcCtD
Felbamate—Dermatitis—Betamethasone—multiple sclerosis	0.000111	0.000365	CcSEcCtD
Felbamate—Fatigue—Methotrexate—multiple sclerosis	0.00011	0.000363	CcSEcCtD
Felbamate—Headache—Dexamethasone—multiple sclerosis	0.00011	0.000363	CcSEcCtD
Felbamate—Headache—Betamethasone—multiple sclerosis	0.00011	0.000363	CcSEcCtD
Felbamate—Asthenia—Prednisone—multiple sclerosis	0.00011	0.000362	CcSEcCtD
Felbamate—Pain—Methotrexate—multiple sclerosis	0.000109	0.00036	CcSEcCtD
Felbamate—Pruritus—Prednisone—multiple sclerosis	0.000108	0.000357	CcSEcCtD
Felbamate—Feeling abnormal—Methotrexate—multiple sclerosis	0.000105	0.000347	CcSEcCtD
Felbamate—Diarrhoea—Prednisone—multiple sclerosis	0.000105	0.000345	CcSEcCtD
Felbamate—Gastrointestinal pain—Methotrexate—multiple sclerosis	0.000105	0.000345	CcSEcCtD
Felbamate—Nausea—Dexamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Felbamate—Nausea—Betamethasone—multiple sclerosis	0.000104	0.000344	CcSEcCtD
Felbamate—Urticaria—Methotrexate—multiple sclerosis	0.000102	0.000335	CcSEcCtD
Felbamate—Dizziness—Prednisone—multiple sclerosis	0.000101	0.000334	CcSEcCtD
Felbamate—Abdominal pain—Methotrexate—multiple sclerosis	0.000101	0.000333	CcSEcCtD
Felbamate—Body temperature increased—Methotrexate—multiple sclerosis	0.000101	0.000333	CcSEcCtD
Felbamate—Vomiting—Prednisone—multiple sclerosis	9.72e-05	0.000321	CcSEcCtD
Felbamate—Rash—Prednisone—multiple sclerosis	9.64e-05	0.000318	CcSEcCtD
Felbamate—GRIN2B—Neuronal System—KCNA3—multiple sclerosis	9.64e-05	0.0227	CbGpPWpGaD
Felbamate—Dermatitis—Prednisone—multiple sclerosis	9.63e-05	0.000318	CcSEcCtD
Felbamate—GRIN2B—Axon guidance—CD24—multiple sclerosis	9.59e-05	0.0226	CbGpPWpGaD
Felbamate—Headache—Prednisone—multiple sclerosis	9.58e-05	0.000316	CcSEcCtD
Felbamate—Asthenia—Methotrexate—multiple sclerosis	9.17e-05	0.000302	CcSEcCtD
Felbamate—Nausea—Prednisone—multiple sclerosis	9.08e-05	0.0003	CcSEcCtD
Felbamate—Pruritus—Methotrexate—multiple sclerosis	9.04e-05	0.000298	CcSEcCtD
Felbamate—Diarrhoea—Methotrexate—multiple sclerosis	8.75e-05	0.000288	CcSEcCtD
Felbamate—Dizziness—Methotrexate—multiple sclerosis	8.45e-05	0.000279	CcSEcCtD
Felbamate—GRIN2A—Alzheimers Disease—TNFRSF1A—multiple sclerosis	8.32e-05	0.0196	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	8.22e-05	0.0194	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	8.22e-05	0.0194	CbGpPWpGaD
Felbamate—Vomiting—Methotrexate—multiple sclerosis	8.13e-05	0.000268	CcSEcCtD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	8.11e-05	0.0191	CbGpPWpGaD
Felbamate—CYP2E1—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	8.11e-05	0.0191	CbGpPWpGaD
Felbamate—Rash—Methotrexate—multiple sclerosis	8.06e-05	0.000266	CcSEcCtD
Felbamate—Dermatitis—Methotrexate—multiple sclerosis	8.05e-05	0.000266	CcSEcCtD
Felbamate—Headache—Methotrexate—multiple sclerosis	8.01e-05	0.000264	CcSEcCtD
Felbamate—Nausea—Methotrexate—multiple sclerosis	7.59e-05	0.00025	CcSEcCtD
Felbamate—GRIN2B—Alzheimers Disease—TNFRSF1A—multiple sclerosis	7.08e-05	0.0167	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—CD24—multiple sclerosis	6.85e-05	0.0161	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	6.66e-05	0.0157	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	6.66e-05	0.0157	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	6.34e-05	0.0149	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	6.34e-05	0.0149	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	6.26e-05	0.0147	CbGpPWpGaD
Felbamate—CYP2C19—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	6.26e-05	0.0147	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP24A1—multiple sclerosis	6e-05	0.0141	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—CYP27B1—multiple sclerosis	6e-05	0.0141	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—FAS—multiple sclerosis	5.72e-05	0.0135	CbGpPWpGaD
Felbamate—GRIN2A—CREB phosphorylation through the activation of Ras—MAPK1—multiple sclerosis	5.68e-05	0.0134	CbGpPWpGaD
Felbamate—CYP3A4—Irinotecan Pathway—BCHE—multiple sclerosis	5.32e-05	0.0125	CbGpPWpGaD
Felbamate—GRIN2A—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	5.25e-05	0.0124	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—APOE—multiple sclerosis	5.25e-05	0.0124	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	5.14e-05	0.0121	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	5.14e-05	0.0121	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—FAS—multiple sclerosis	4.86e-05	0.0115	CbGpPWpGaD
Felbamate—GRIN2B—CREB phosphorylation through the activation of Ras—MAPK1—multiple sclerosis	4.83e-05	0.0114	CbGpPWpGaD
Felbamate—GRIN2A—Post NMDA receptor activation events—MAPK1—multiple sclerosis	4.68e-05	0.011	CbGpPWpGaD
Felbamate—GRIN2B—Hypothetical Network for Drug Addiction—MAPK1—multiple sclerosis	4.47e-05	0.0105	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—APOE—multiple sclerosis	4.46e-05	0.0105	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—CNR1—multiple sclerosis	4.35e-05	0.0102	CbGpPWpGaD
Felbamate—GRIN2A—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	4.31e-05	0.0101	CbGpPWpGaD
Felbamate—CYP2E1—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	4.23e-05	0.00997	CbGpPWpGaD
Felbamate—GRIN2B—ErbB4 signaling events—MAPK1—multiple sclerosis	4.16e-05	0.00979	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—BCHE—multiple sclerosis	4.15e-05	0.00977	CbGpPWpGaD
Felbamate—GRIN2B—Post NMDA receptor activation events—MAPK1—multiple sclerosis	3.98e-05	0.00937	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP27B1—multiple sclerosis	3.81e-05	0.00898	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—CYP24A1—multiple sclerosis	3.81e-05	0.00898	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP27B1—multiple sclerosis	3.76e-05	0.00886	CbGpPWpGaD
Felbamate—CYP3A4—Oxidation by Cytochrome P450—CYP24A1—multiple sclerosis	3.76e-05	0.00886	CbGpPWpGaD
Felbamate—GRIN2B—Activation of NMDA receptor upon glutamate binding and postsynaptic events—MAPK1—multiple sclerosis	3.66e-05	0.00863	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP27B1—multiple sclerosis	3.54e-05	0.00833	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—CYP24A1—multiple sclerosis	3.54e-05	0.00833	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—BCHE—multiple sclerosis	3.53e-05	0.00831	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—BDNF—multiple sclerosis	3.51e-05	0.00828	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP27B1—multiple sclerosis	3.49e-05	0.00822	CbGpPWpGaD
Felbamate—CYP2E1—Metapathway biotransformation—CYP24A1—multiple sclerosis	3.49e-05	0.00822	CbGpPWpGaD
Felbamate—CYP3A4—Drug Induction of Bile Acid Pathway—VDR—multiple sclerosis	3.42e-05	0.00806	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—IL1B—multiple sclerosis	3.35e-05	0.00788	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—BCHE—multiple sclerosis	3.18e-05	0.00749	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PRNP—multiple sclerosis	3.16e-05	0.00746	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—SPP1—multiple sclerosis	3.12e-05	0.00735	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP24A1—multiple sclerosis	3.09e-05	0.00728	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—CYP27B1—multiple sclerosis	3.09e-05	0.00728	CbGpPWpGaD
Felbamate—CYP2C19—Melatonin metabolism and effects—APOE—multiple sclerosis	2.97e-05	0.00699	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—IL1B—multiple sclerosis	2.84e-05	0.0067	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP27B1—multiple sclerosis	2.73e-05	0.00643	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—CYP24A1—multiple sclerosis	2.73e-05	0.00643	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—BCHE—multiple sclerosis	2.7e-05	0.00637	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP24A1—multiple sclerosis	2.69e-05	0.00634	CbGpPWpGaD
Felbamate—CYP2C19—Metapathway biotransformation—CYP27B1—multiple sclerosis	2.69e-05	0.00634	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—MAPK1—multiple sclerosis	2.55e-05	0.00601	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—PTPRC—multiple sclerosis	2.46e-05	0.0058	CbGpPWpGaD
Felbamate—GRIN2A—Alzheimers Disease—TNF—multiple sclerosis	2.43e-05	0.00572	CbGpPWpGaD
Felbamate—GRIN2B—EPH-Ephrin signaling—MMP9—multiple sclerosis	2.33e-05	0.0055	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PRNP—multiple sclerosis	2.26e-05	0.00532	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—MAPK1—multiple sclerosis	2.17e-05	0.00511	CbGpPWpGaD
Felbamate—GRIN2B—Alzheimers Disease—TNF—multiple sclerosis	2.06e-05	0.00486	CbGpPWpGaD
Felbamate—CYP3A4—Nuclear Receptors in Lipid Metabolism and Toxicity—VDR—multiple sclerosis	1.96e-05	0.00463	CbGpPWpGaD
Felbamate—CYP2E1—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.85e-05	0.00435	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—PTPRC—multiple sclerosis	1.76e-05	0.00414	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP27B1—multiple sclerosis	1.64e-05	0.00387	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—CYP24A1—multiple sclerosis	1.64e-05	0.00387	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP27B1—multiple sclerosis	1.62e-05	0.00381	CbGpPWpGaD
Felbamate—CYP3A4—Metapathway biotransformation—CYP24A1—multiple sclerosis	1.62e-05	0.00381	CbGpPWpGaD
Felbamate—GRIN2A—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.61e-05	0.0038	CbGpPWpGaD
Felbamate—CYP2E1—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.5e-05	0.00353	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—STAT3—multiple sclerosis	1.48e-05	0.00348	CbGpPWpGaD
Felbamate—CYP2C19—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	1.43e-05	0.00336	CbGpPWpGaD
Felbamate—GRIN2B—Neurotransmitter Receptor Binding And Downstream Transmission In The Postsynaptic Cell—MAPK1—multiple sclerosis	1.37e-05	0.00323	CbGpPWpGaD
Felbamate—CYP2E1—Vitamin A and Carotenoid Metabolism—MAPK1—multiple sclerosis	1.36e-05	0.00321	CbGpPWpGaD
Felbamate—GRIN2B—BDNF signaling pathway—MAPK1—multiple sclerosis	1.34e-05	0.00316	CbGpPWpGaD
Felbamate—GRIN2A—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.21e-05	0.00286	CbGpPWpGaD
Felbamate—CYP2C19—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	1.16e-05	0.00272	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—TYK2—multiple sclerosis	1.1e-05	0.00259	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP27B1—multiple sclerosis	1.05e-05	0.00247	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—CYP24A1—multiple sclerosis	1.05e-05	0.00247	CbGpPWpGaD
Felbamate—GRIN2B—Transmission across Chemical Synapses—MAPK1—multiple sclerosis	1.03e-05	0.00243	CbGpPWpGaD
Felbamate—GRIN2A—Neuronal System—MAPK1—multiple sclerosis	9.29e-06	0.00219	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MMP9—multiple sclerosis	8.67e-06	0.00204	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—SRM—multiple sclerosis	8.59e-06	0.00202	CbGpPWpGaD
Felbamate—CYP3A4—Cytochrome P450 - arranged by substrate type—POMC—multiple sclerosis	8.58e-06	0.00202	CbGpPWpGaD
Felbamate—CYP2E1—Biological oxidations—POMC—multiple sclerosis	7.96e-06	0.00187	CbGpPWpGaD
Felbamate—GRIN2B—Neuronal System—MAPK1—multiple sclerosis	7.9e-06	0.00186	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TYK2—multiple sclerosis	7.86e-06	0.00185	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—MAPK1—multiple sclerosis	7.01e-06	0.00165	CbGpPWpGaD
Felbamate—CYP3A4—Phase 1 - Functionalization of compounds—POMC—multiple sclerosis	6.95e-06	0.00164	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—SRM—multiple sclerosis	6.63e-06	0.00156	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MMP9—multiple sclerosis	6.19e-06	0.00146	CbGpPWpGaD
Felbamate—CYP2C19—Biological oxidations—POMC—multiple sclerosis	6.14e-06	0.00145	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP27B1—multiple sclerosis	6.05e-06	0.00143	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—CYP24A1—multiple sclerosis	6.05e-06	0.00143	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—GPC5—multiple sclerosis	5.53e-06	0.0013	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—STAT3—multiple sclerosis	5.5e-06	0.0013	CbGpPWpGaD
Felbamate—GRIN2B—Axon guidance—IL6—multiple sclerosis	5.39e-06	0.00127	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TGFB1—multiple sclerosis	5.1e-06	0.0012	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—MAPK1—multiple sclerosis	5e-06	0.00118	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—TNF—multiple sclerosis	4.76e-06	0.00112	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP27B1—multiple sclerosis	4.67e-06	0.0011	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—CYP24A1—multiple sclerosis	4.67e-06	0.0011	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—RRM1—multiple sclerosis	4.59e-06	0.00108	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—BCHE—multiple sclerosis	4.56e-06	0.00107	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—GPC5—multiple sclerosis	4.27e-06	0.00101	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—SRM—multiple sclerosis	3.98e-06	0.000939	CbGpPWpGaD
Felbamate—GRIN2B—Developmental Biology—IL6—multiple sclerosis	3.84e-06	0.000905	CbGpPWpGaD
Felbamate—CYP3A4—Biological oxidations—POMC—multiple sclerosis	3.69e-06	0.00087	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—RRM1—multiple sclerosis	3.54e-06	0.000833	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP24A1—multiple sclerosis	2.81e-06	0.000661	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—CYP27B1—multiple sclerosis	2.81e-06	0.000661	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—APOE—multiple sclerosis	2.74e-06	0.000647	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—BCHE—multiple sclerosis	2.63e-06	0.00062	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—GPC5—multiple sclerosis	2.57e-06	0.000605	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—POMC—multiple sclerosis	2.36e-06	0.000555	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism of lipids and lipoproteins—ALB—multiple sclerosis	2.15e-06	0.000506	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—RRM1—multiple sclerosis	2.13e-06	0.000501	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—BCHE—multiple sclerosis	2.03e-06	0.000479	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—APOE—multiple sclerosis	1.58e-06	0.000373	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—POMC—multiple sclerosis	1.36e-06	0.000321	CbGpPWpGaD
Felbamate—CYP2E1—Metabolism—ALB—multiple sclerosis	1.24e-06	0.000292	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—APOE—multiple sclerosis	1.22e-06	0.000288	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—BCHE—multiple sclerosis	1.22e-06	0.000288	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—POMC—multiple sclerosis	1.05e-06	0.000247	CbGpPWpGaD
Felbamate—CYP2C19—Metabolism—ALB—multiple sclerosis	9.57e-07	0.000226	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—APOE—multiple sclerosis	7.35e-07	0.000173	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—POMC—multiple sclerosis	6.31e-07	0.000149	CbGpPWpGaD
Felbamate—CYP3A4—Metabolism—ALB—multiple sclerosis	5.76e-07	0.000136	CbGpPWpGaD
